Although Hailstorm missed the big short term move up, he was on the money regarding the data, or lack there of, and managements continued poor execution. Months ago I promised to return after this data was released, and "tip my hat" to hailstorm if he was right.
Bottom line, I thought management again over promised and under delivered. This data release was way too early, inconclusive, and amateurish. The Conf. call was really bad too. In time Synta may prove to have an approvable drug, but for now I am not feeling overly confidant about this bunch.